We are live on ! Find out more
CGTX icon

Cognition Therapeutics
CGTX

40 hedge funds and large institutions have $1.99M invested in Cognition Therapeutics in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

2.66% less ownership

Funds ownership: 13.26% → 10.6% (-2.7%)

13% less funds holding

Funds holding: 46 → 40 (-6)

36% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 14

77% less capital invested

Capital invested by funds: $8.82M → $1.99M (-$6.82M)

Holders
40
Holders Change
-6
Holders Change %
-13.04%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
5
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$204K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$145K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$97.9K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$81.3K
5
VF
Virtu Financial
New York
+$59K

Top Sellers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
-$1.08M
2
TIM
Timelo Investment Management
Ontario, Canada
-$600K
3
ACM
AIGH Capital Management
Maryland
-$499K
4
CC
Carlson Capital
Texas
-$232K
5
CCM
Corsair Capital Management
New York
-$129K
Name Holding Trade Value Shares
Change 		Change in
Stake
Mercer Global Advisors
26
Mercer Global Advisors
Colorado
$7.07K -$82.4K -79,900 -83%
Bessemer Group
27
Bessemer Group
New Jersey
$6K +$14.2K +13,797 New
SAF
28
Smith Anglin Financial
Texas
$5.62K – – –
Two Sigma Investments
29
Two Sigma Investments
New York
$5.33K +$11.7K +11,370 New
Two Sigma Advisers
30
Two Sigma Advisers
New York
$5.16K +$11.3K +11,000 New
TRCT
31
Tower Research Capital (TRC)
New York
$5.15K +$370 +359 +3%
RJA
32
Raymond James & Associates
Florida
$4.69K – – –
Northwestern Mutual Wealth Management
33
Northwestern Mutual Wealth Management
Wisconsin
$2.75K – – –
Bank of America
34
Bank of America
North Carolina
$2.47K +$63 +61 +1%
BCA
35
Bray Capital Advisors
Florida
$1.05K – – –
Osaic Holdings
36
Osaic Holdings
Arizona
$846 +$1.86K +1,800 New
Morgan Stanley
37
Morgan Stanley
New York
$469 -$2.06K -2,000 -67%
Wells Fargo
38
Wells Fargo
California
$469 – – –
JP Morgan Chase
39
JP Morgan Chase
New York
$37 +$80 +78 New
AIC
40
AWM Investment Company
New York
– -$1.08M -650,000 Closed
TIM
41
Timelo Investment Management
Ontario, Canada
– -$600K -361,397 Closed
ACM
42
AIGH Capital Management
Maryland
– -$499K -300,766 Closed
CC
43
Carlson Capital
Texas
– -$232K -140,000 Closed
CCM
44
Corsair Capital Management
New York
– -$129K -77,433 Closed
Envestnet Asset Management
45
Envestnet Asset Management
Illinois
– -$49.8K -30,000 Closed
Citadel Advisors
46
Citadel Advisors
Florida
– -$44.7K -26,950 Closed
Baird Financial Group
47
Baird Financial Group
Wisconsin
– -$37.2K -22,393 Closed
Millennium Management
48
Millennium Management
New York
– -$22.6K -13,624 Closed
Charles Schwab
49
Charles Schwab
California
– -$19.9K -11,965 Closed
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
– -$16.9K -10,182 Closed
1
2
3

CGTX Hedge Fund Activity: Q3 2024 in Review

40 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cognition Therapeutics (CGTX) for Q3 2024, worth a combined $1.99M — down 77% from $8.82M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CGTX and 9 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 7 added.

The largest buyer was UBS Group, opening a new position worth an estimated $204K. The largest seller was AWM Investment Company, exiting entirely with an estimated $1.08M sold.

  • 40 institutional investors held Cognition Therapeutics (CGTX) as of Q3 2024, down from 46 in Q2 2024.
  • Funds reported $1.99M of Cognition Therapeutics stock for Q3 2024, down 77% quarter-over-quarter.
  • 9 funds opened new Cognition Therapeutics positions in Q3 2024 and 14 closed out, a net change of -5 holders.
  • The largest Cognition Therapeutics buyer in Q3 2024 was UBS Group, an estimated $204K added.
  • The largest Cognition Therapeutics seller in Q3 2024 was AWM Investment Company, an estimated $1.08M sold.

Based on aggregated 13F filings for Q3 2024.